Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole injection for prevention of delayed chemotherapy-induced nausea
ChiCTR1900022107Phase 4Recruiting
- Sponsor
- Tongji Hospital
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esomeprazole in chemotherapy-induced nausea and vomiting (CINV), sponsored by Tongji Hospital. Primary endpoints: Complete response rate of chemotherapy-induced nausea and ECOG physical status score. Started Apr 2019; status: recruiting.
02
Drugs
esomeprazole
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on ChiCTR1900022107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022107.